细胞外基质
细胞生物学
整合素
CD44细胞
细胞粘附
基质金属蛋白酶
生物
血管生成
弹性蛋白
糖胺聚糖
细胞
细胞粘附分子
生物化学
遗传学
作者
Nikos K. Karamanos,Achilleas D. Theocharis,Zoi Piperigkou,Dimitra Manou,Alberto Passi,Spyros S. Skandalis,Demitrios H. Vynios,Véronique Orian‐Rousseau,Sylvie Ricard‐Blum,Christian E.H. Schmelzer,Laurent Duca,Madeleine Durbeej,Nikolaos A. Afratis,Linda Troeberg,Marco Franchi,Valentina Masola,Maurizio Onisto
出处
期刊:FEBS Journal
[Wiley]
日期:2021-02-21
卷期号:288 (24): 6850-6912
被引量:986
摘要
Extracellular matrix (ECM) is a dynamic 3-dimensional network of macromolecules that provides structural support for the cells and tissues. Accumulated knowledge clearly demonstrated over the last decade that ECM plays key regulatory roles since it orchestrates cell signaling, functions, properties and morphology. Extracellularly secreted as well as cell-bound factors are among the major members of the ECM family. Proteins/glycoproteins, such as collagens, elastin, laminins and tenascins, proteoglycans and glycosaminoglycans, hyaluronan, and their cell receptors such as CD44 and integrins, responsible for cell adhesion, comprise a well-organized functional network with significant roles in health and disease. On the other hand, enzymes such as matrix metalloproteinases and specific glycosidases including heparanase and hyaluronidases contribute to matrix remodeling and affect human health. Several cell processes and functions, among them cell proliferation and survival, migration, differentiation, autophagy, angiogenesis, and immunity regulation are affected by certain matrix components. Structural alterations have been also well associated with disease progression. This guide on the composition and functions of the ECM gives a broad overview of the matrisome, the major ECM macromolecules, and their interaction networks within the ECM and with the cell surface, summarizes their main structural features and their roles in tissue organization and cell functions, and emphasizes the importance of specific ECM constituents in disease development and progression as well as the advances in molecular targeting of ECM to design new therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI